ÆÁÅçʸÍýÂç³Ø

Web¥·¥é¥Ð¥¹¥·¥¹¥Æ¥à

TOP Ìá¤ë
ÆÁÅçʸÍýÂç³Øû´üÂç³ØÉô

Ìô³Ø²Ê

160²ÊÌÜ
²ÊÌÜ̾ ôÅö¶µ°÷ ³«¹Ö´ü ñ°Ì¿ô Íú½¤Ç¯ÅÙ
¢£Ê¸³ØA(LiteratureA) ¹âȪ¡¡¾ï¿® Á°´ü 2 1ǯ¡Á
¢£Å¯³ØA Ω»³¡¡Á±¹¯ ¸å´ü 2 1ǯ
¢£Ë¡³ØA(ÆüËܹñ·ûË¡) ¶¶ËÜ¡¡À¿»Ö Á°´ü 2 1ǯ
¢£¿´Íý³ØA ¸¶ÅÄ¡¡¹ÌÂÀϺ Á°´ü 2 1ǯ
¢£·ÐºÑ³ØA ÆîÇÈ¡¡¹À»Ë ¸å´ü 2 1ǯ
¢£¾ðÊó½èÍý Ãæ¾ò¡¡µÁµ± Á°´ü 2 1ǯ
¢£¿ô³ØA ̾±Û¡¡°ìÆó»° Á°´ü 2 1ǯ
¢£¿ô³ØB ̾±Û¡¡°ìÆó»° ¸å´ü 2 1ǯ
¢£ÊªÍý³ØAa ´ßËÜ¡¡ÂÙ»Ê Á°´ü 2 1ǯ
¢£ÊªÍý³ØAb ¿¢ÌÚ¡¡ÀµÆó Á°´ü 2 1ǯ
¢£ÊªÍý³ØBa °ËÆ£¡¡±Ùϯ Á°´ü 2 1ǯ
¢£ÊªÍý³ØBb °ËÆ£¡¡±Ùϯ Á°´ü 2 1ǯ
¢£²½³ØA ´îǼ¡¡¹î¿Î Á°´ü 2 1ǯ
¢£²½³ØB ´îǼ¡¡¹î¿Î Á°´ü 2 1ǯ
¢£±þÍÑÀ¸Êª³ØA ̧ÅÄ¡¡¹¯°ì Á°´ü 2 1ǯ
¢£±þÍÑÀ¸Êª³ØB ¹â¶¶¡¡ÃÎ»Ò Á°´ü 2 1ǯ
¢£·ò¹¯¥¹¥Ý¡¼¥ÄA ÅĻҡ¡¹§¿Î Á°´ü 1 1ǯ
¢£·ò¹¯¥¹¥Ý¡¼¥ÄB ÅĻҡ¡¹§¿Î ¸å´ü 1 1ǯ
¢£±Ñ¸ìA­¡a °¤Éô¡¡¹¸Ä¾ Á°´ü 1 1ǯ
¢£±Ñ¸ìA­¡b ÃæÅç¡¡ÀµÂÀ Á°´ü 1 1ǯ
¢£±Ñ¸ìA­¢a °¤Éô¡¡¹¸Ä¾ ¸å´ü 1 1ǯ
¢£±Ñ¸ìA­¢b ÃæÅç¡¡ÀµÂÀ ¸å´ü 1 1ǯ
¢£±Ñ¸ì£Â­¡a Nicholas Hawkins Á°´ü 1 2ǯ
¢£±Ñ¸ì£Â­¡b SilviaCanalini Á°´ü 1 2ǯ
¢£±Ñ¸ì£Â­¢a Nicholas Hawkins ¸å´ü 1 2ǯ
¢£±Ñ¸ì£Â­¢b SilviaCanalini ¸å´ü 1 2ǯ
¢£ÆȸìA­¡ °æ¾å¡¡ÊÙ Á°´ü 1 1ǯ
¢£Æȸì£Á­¢ °æ¾å¡¡ÊÙ ¸å´ü 1 1ǯ
¢£Ê¸Íý³Ø ÆÀ´Ý¡¡Çî»Ë Á°´ü 2 1ǯ
¢£Ìô³Ø³µÏÀ ´Ý»³¡¡ÆÁ¸« Á°´ü 1 1ǯ
¢£Áá´üÂθ³³Ø½¬ ´äÅÄ¡¡À¿ ¸å´ü 0.5 1ǯ
¢£¿Í´Ö´Ø·¸ÏÀ ¸¶ÅÄ¡¡¹ÌÂÀϺ ¸å´ü 1.5 1ǯ
¢£°åÎÅ¥³¥ß¥å¥Ë¥±¡¼¥·¥ç¥óÆþÌç ¸¶ÅÄ¡¡¹ÌÂÀϺ Á°´ü 1.5 2ǯ
¢£°åÎÅÎÑÍý³Ø Ω»³¡¡Á±¹¯ ¸å´ü 1.5 2ǯ
¢£°åÎżҲñÌô³Ø¥³¥ß¥å¥Ë¥±¡¼¥·¥ç¥ó³Ø ²£ÅÄ¡¡¤Ò¤È¤ß Á°´ü 1 5ǯ
¢£Ìô³Ø¿ô³ØÆþÌç ´îǼ¡¡¹î¿Î Á°´ü 0.5 1ǯ
¢£ÊªÍý²½³Ø£± ´ßËÜ¡¡ÂÙ»Ê ¸å´ü 1.5 1ǯ
¢£ÊªÍý²½³Ø2 ¿¢ÌÚ¡¡ÀµÆó ¸å´ü 1.5 2ǯ
¢£À¸²½³Ø£± µÜß·¡¡¹¨ ¸å´ü 1.5 1ǯ
¢£Ê¬Àϲ½³Ø£± »³¸ý¡¡·òÂÀϺ Á°´ü 1.5 2ǯ
¢£Ê¬Àϲ½³Ø£² »³¸ý¡¡·òÂÀϺ Á°´ü 1.5 2ǯ
¢£Ê¬Àϲ½³Ø£³ »³¸ý¡¡·òÂÀϺ Á°´ü 1.5 2ǯ
¢£´ðÁÃÍ­µ¡²½³Ø£± ´Ý»³¡¡ÆÁ¸« ¸å´ü 1.5 1ǯ
¢£´ðÁÃÍ­µ¡²½³Ø2 ´Ý»³¡¡ÆÁ¸« ¸å´ü 1.5 1ǯ
¢£Í­µ¡²½³Ø£± Éٱʡ¡¾»±Ñ Á°´ü 1.5 2ǯ
¢£Í­µ¡²½³Ø£² Éٱʡ¡¾»±Ñ Á°´ü 1.5 2ǯ
¢£Í­µ¡²½³Ø3 Æ£Åç¡¡Íø¹¾ ¸å´ü 1.5 2
¢£È¿±þÍ­µ¡²½³Ø Éٱʡ¡¾»±Ñ Á°´ü 1.5 3ǯ
¢£°åÎŲʳØ1¡ÊPharmaceutical Health Science¡Ë ÌîÃÏ¡¡ÍµÈþ Á°´ü 1.5 3ǯ
¢£ÌôÍÑ»ñ¸»³Ø ´ØÅÄ¡¡Àá»Ò ¸å´ü 1.5 1
¢£ÌôÍÑ»ñ¸»³Ø¡ÊMedicinal Resources Science¡Ë ÂåÅÄ¡¡½¤ ¸å´ü 1.5 1
¢£À¸Ìô³Ø¡ÊPharmacognosy¡Ë ÂåÅÄ¡¡½¤ Á°´ü 1.5 2
¢£À¸Ìô³Ø ´ØÅÄ¡¡Àá»Ò Á°´ü 1.5 2
¢£Å·Á³Êª²½³Ø¡ÊNatural Products Chemistry¡Ë ÂåÅÄ¡¡½¤ ¸å´ü 1.5 2
¢£ÅìÍΰå³Ø³µÏÀ ´ØÅÄ¡¡Àá»Ò Á°´ü 1.5 3
¢£ºÙ˦À¸Êª³Ø ¹â¶¶¡¡ÃÎ»Ò ¸å´ü 1.5 1
¢£À¸ÊªÊªÍý³Ø ´ßËÜ¡¡ÂÙ»Ê ¸å´ü 1.5 2ǯ
¢£µ¡Ç½·ÁÂֳأ± ¹â¶¶¡¡ÃÎ»Ò ¸å´ü 1.5 1
¢£µ¡Ç½·ÁÂֳأ² ÅÏî´¡¡ÀµÃÎ Á°´ü 1.5 2
¢£À¸²½³Ø£² ´îǼ¡¡¹î¿Î Á°´ü 1.5 2
¢£Ê¬»ÒÀ¸Êª³Ø µÜß·¡¡¹¨ ¸å´ü 1.5 2ǯ
¢£ÈùÀ¸Êª³Ø1 ÂçÅ硡δ¹¬ Á°´ü 1.5 2
¢£ÈùÀ¸Êª³Ø2 ÂçÅ硡δ¹¬ ¸å´ü 1 2
¢£±ÒÀ¸Ìô³Ø£±¡ÊPharmaceutical Health Science¡¡1¡Ë ÌîÃÏ¡¡ÍµÈþ ¸å´ü 1.5 2ǯ
¢£ÌôÍý³ØA ¾®À¾¡¡»Ëϯ ¸å´ü 1.5 2
¢£ÌôÍý³ØA ÆÀ´Ý¡¡Çî»Ë ¸å´ü 1.5 2
¢£ÌôÍý³ØB ¾®À¾¡¡»Ëϯ Á°´ü 1.5 3
¢£ÌôÍý³ØC ¾®À¾¡¡»Ëϯ ¸å´ü 1.5 3
¢£ÌôÍý³ØD ¾®À¾¡¡»Ëϯ Á°´ü 1.5 4
¢£±ÒÀ¸²½³Ø2 ÃÝÆâ¡¡°ì Á°´ü 1.5 3
¢£±ÒÀ¸²½³Ø£³ Â粬¡¡²Å¼£ Á°´ü 1.5 3
¢£²½³ØÎÅË¡³Ø µÜß·¡¡¹¨ Á°´ü 1.5 3ǯ
¢£ÉÂÂÖÀ¸Íý³Ø1 Áס¡»þ±É Á°´ü 1.5 3
¢£ÌôºÞ³Ø£±¡ÊBiopharmaceutics 1¡Ë ²ÃÆ£¡¡Á±µ× Á°´ü 1.5 3
¢£À½ºÞ³Ø£±¡ÊPharmaceutics 1¡Ë ÆÁ¼¡¡Ãé°ì ¸å´ü 1.5 3ǯ
¢£ÌôºÞ³Ø£²¡ÊBiopharmaceutics 2¡Ë ºç¸¶¡¡µªÏ ¸å´ü 1.5 3
¢£ÌôºÞ³Ø£²¡ÊBiopharmaceutics 2¡Ë ²ÃÆ£¡¡Á±µ× ¸å´ü 1.5 3
¢£À¸Êª¼Â½¬ ´ßËÜ¡¡ÂÙ»Ê Á°´ü 1 2ǯ
¢£²½³Ø¼Â½¬ ¿¢ÌÚ¡¡ÀµÆó Á°´ü 1 2ǯ
¢£²½³Ø¼Â½¬(1-20) Æ£Åç¡¡Íø¹¾ Á°´ü 2 2
¢£²½³Ø¼Â½¬(21-40) Æ£Åç¡¡Íø¹¾ Á°´ü 2 2
¢£À¸Ìô³Ø¼Â½¬¡ÊPractice in Pharmacognosy and Natural Products Chemistry¡Ë ÂåÅÄ¡¡½¤ Á°´ü 1 2
¢£ÊªÍý²½³Ø¼Â½¬ »³¸ý¡¡·òÂÀϺ ¸å´ü 1.5 2
¢£À¸²½³Ø¼Â½¬ ¹â¶¶¡¡ÃÎ»Ò ¸å´ü 1.5 2
¢£°åÌô²½³Ø1 Æ£Åç¡¡Íø¹¾ ¸å´ü 1.5 3
¢£ÌÈ±Ö³Ø ´äÅÄ¡¡À¿ ¸å´ü 1.5 3ǯ
¢£À½ºÞ³Ø2¡ÊPharmaceutics 2¡Ë ÆÁ¼¡¡Ãé°ì Á°´ü 1.5 4ǯ
¢£À¸ÊªÊªÍý³Ø£² °ËÆ£¡¡±Ùϯ Á°´ü 1.5 3ǯ
¢£°åÌôÉÊ°ÂÁ´À­³Ø¡ÊPharmacotherapeutic Toxicology¡Ë ÆóµÜ¡¡¾»¼ù ¸å´ü 1.5 3
¢£ÉÂÂÖÀ¸Íý³Ø2 Áס¡»þ±É ¸å´ü 1.5 3
¢£Êü¼ÍÀþ²Ê³Ø ¿¢ÌÚ¡¡ÀµÆó Á°´ü 1.5 3ǯ
¢£°åÌôÉʾðÊó³Ø ÈÓ¸¶¡¡¤Ê¤ª¤ß Á°´ü 1.5 3
¢£À¸ÊªÅý·×³Ø °ËÆ£¡¡±Ùϯ ¸å´ü 1 3ǯ
¢£Ìô³Ø¼Â½¬£²£Á Â粬¡¡²Å¼£ Á°´ü 2 3
¢£Ìô³Ø¼Â½¬2A ´äÅÄ¡¡À¿ Á°´ü 2 3
¢£Ìô³Ø¼Â½¬2(A) ´Ý»³¡¡ÆÁ¸« Á°´ü 2 3
¢£Ìô³Ø¼Â½¬2£Â¡ÊPractice in Pharmaceutical Science 2(B)¡Ë ÌîÃÏ¡¡ÍµÈþ Á°´ü 2 3
¢£Ìô³Ø¼Â½¬2B ÃÝÆâ¡¡°ì Á°´ü 2 3
¢£Ìô³Ø¼Â½¬2C ¾®À¾¡¡»Ëϯ Á°´ü 2 3
¢£Ìô³Ø¼Â½¬ 2C (1-29) ÅÏî´¡¡ÀµÃÎ Á°´ü 2 3
¢£Ìô³Ø¼Â½¬ 2C (30-40) ÅÏî´¡¡ÀµÃÎ Á°´ü 2 3
¢£Ìô³Ø¼Â½¬ 2C (1-29) ÆÀ´Ý¡¡Çî»Ë Á°´ü 2 3
¢£Ìô³Ø¼Â½¬ 2C (30-40) ÆÀ´Ý¡¡Çî»Ë Á°´ü 2 3
¢£Ìô³Ø¼Â½¬ 2C (1-29) °ËÆ£¡¡¹¯°ì Á°´ü 2 3
¢£Ìô³Ø¼Â½¬ 2C (30-40) °ËÆ£¡¡¹¯°ì Á°´ü 2 3
¢£Ìô³Ø¼Â½¬£³¡ÊA¡Ë Áס¡»þ±É ¸å´ü 2 3
¢£Ìô³Ø¼Â½¬£³£Á ¾®À¾¡¡»Ëϯ ¸å´ü 2 3
¢£Ìô³Ø¼Â½¬£³¡Ê£Â¡Ë(1-30) ·ªÅÄ¡¡Âóϯ ¸å´ü 2 3
¢£Ìô³Ø¼Â½¬£³¡Ê£Â¡Ë(31-40) ·ªÅÄ¡¡Âóϯ ¸å´ü 2 3
¢£Ìô³Ø¼Â½¬£³C¡Ê¸å´ü1-30¡Ë¡ÊPractice in Pharmaceutical Science 3(C)¡Ë ²ÃÆ£¡¡Á±µ× ¸å´ü 2 3
¢£Ìô³Ø¼Â½¬£³C¡Ê¸å´ü1-30¡Ë¡ÊPractice in Pharmaceutical Science 3(C)¡Ë ºç¸¶¡¡µªÏ ¸å´ü 2 3
¢£Ìô³Ø¼Â½¬£³C¡Ê¸å´ü31-40¡Ë¡ÊPractice in Pharmaceutical Science 3(C)¡Ë ²ÃÆ£¡¡Á±µ× ¸å´ü 2 3
¢£Ìô³Ø¼Â½¬£³C¡Ê¸å´ü31-40¡Ë¡ÊPractice in Pharmaceutical Science 3(C)¡Ë ºç¸¶¡¡µªÏ ¸å´ü 2 3
¢£Î×¾²ÌôºÞ³Ø¡ÊClinical Pharmaceutics¡Ë ÆóµÜ¡¡¾»¼ù Á°´ü 1.5 4
¢£Î×¾²°å³Ø³µÏÀ »°°æ¡¡ÍÎ»Ê Á°´ü 1.5 4
¢£Î×¾²°å³Ø³µÏÀ ¹â¶¶¡¡ÃÎ»Ò Á°´ü 1.5 4
¢£ÌôʪưÂֳءÊPharmacokinetics¡Ë ²ÃÆ£¡¡Á±µ× Á°´ü 1.5 4
¢£ÌôʪưÂֳءÊPharmacokinetics¡Ë ºç¸¶¡¡µªÏ Á°´ü 1.5 4
¢£Ìôʪ¼£Îųأ± °ËÆ£¡¡¹¯°ì Á°´ü 1.5 4
¢£Ìôʪ¼£Îųأ² ÅÏî´¡¡ÀµÃÎ Á°´ü 1.5 4
¢£ÉʼÁ´ÉÍý³Ø ´Ý»³¡¡ÆÁ¸« Á°´ü 1 5
¢£Ìô»ö´Ø·¸Ë¡µ¬£± ´Ý»³¡¡ÆÁ¸« Á°´ü 1.5 4
¢£Ìô»ö´Ø·¸Ë¡µ¬£± ÇòȪ¡¡¹§ÌÀ Á°´ü 1.5 4
¢£Ìô»ö´Ø·¸Ë¡µ¬2 ´Ý»³¡¡ÆÁ¸« Á°´ü 1.5 6
¢£°åÌôÉÊ¡¦°åÎÅ¥Ó¥¸¥Í¥¹ ²£ÅÄ¡¡¤Ò¤È¤ß Á°´ü 1 5
¢£°åÌô·ÐºÑ³Ø ÈÓ¸¶¡¡¤Ê¤ª¤ß Á°´ü 1 6
¢£ÌôÉÊÂå¼Õ²½³Ø¡ÊToxicology¡Ë ÌîÃÏ¡¡ÍµÈþ Á°´ü 1.5 4ǯ
¢£À¸ÂÎʬÀÏ³Ø ·ªÅÄ¡¡Âóϯ Á°´ü 1.5 4
¢£Î×¾²À¸²½³Ø Éڱʡ¡µ®»Ö Á°´ü 1 4
¢£°åÌô²½³Ø£² Æ£Åç¡¡Íø¹¾ Á°´ü 1 4
¢£°åÎŲʳØ2 ´äÅÄ¡¡À¿ Á°´ü 1 4ǯ
¢£À¸ÊªÀ½ºÞ³Ø µÜß·¡¡¹¨ Á°´ü 1 5ǯ
¢£»öÁ°³Ø½¬£±¡ÊÁ°´ü1-35¡Ë¡ÊPreparation for Practical Training¡Ë ÆóµÜ¡¡¾»¼ù Á°´ü 6.5 4
¢£»öÁ°³Ø½¬£±¡ÊÁ°´ü36-69¡Ë¡ÊPreparation for Practical Training¡Ë ÆóµÜ¡¡¾»¼ù Á°´ü 6.5 4
¢£»öÁ°³Ø½¬£±¡ÊÁ°´ü70-84¡Ë¡ÊPreparation for Practical Training¡Ë ÆóµÜ¡¡¾»¼ù Á°´ü 6.5 4
¢£»öÁ°³Ø½¬£²¡Ê¸å´ü1-28¡Ë¡ÊPreparation for Practical Training¡Ë ÆóµÜ¡¡¾»¼ù ¸å´ü 6 4
¢£»öÁ°³Ø½¬£²¡Ê¸å´ü29-38¡Ë¡ÊPreparation for Practical Training¡Ë ÆóµÜ¡¡¾»¼ù ¸å´ü 6 4
¢£ÆÃÊ̼½¬ È÷¹ÍÍ󵭺ܤζµ°÷ ÄÌǯ 10 4¡Á5
¢£É±¡¼Â̳¼Â½¬¡ÊPractical Training in Hospital Pharmacy¡Ë ÆóµÜ¡¡¾»¼ù ÄÌǯ 10 5
¢£Ìô¶É¼Â̳¼Â½¬(Practical Training in Community Pharmacy) ÆóµÜ¡¡¾»¼ù ÄÌǯ 10 5
¢£°åÌôÉʳ«È¯ÆÃÊֵ̹Á ´Ý»³¡¡ÆÁ¸« Á°´ü 1 6
¢£À¸Ì¿²Ê³ØÆÃÊֵ̹Á¡¡ °ËÆ£¡¡¹¯°ì Á°´ü 1 4
¢£Â´¶È¼Â½¬ È÷¹ÍÍ󵭺ܤζµ°÷ ÄÌǯ 12 5¡Á6
¢£¥¢¥É¥Ð¥ó¥¹¥È¶µ°é¥×¥í¥°¥é¥à µÜß·¡¡¹¨ ÄÌǯ 3 £µÇ¯Á°´ü¡Á£¶Ç¯Á°´ü
¢£¥¢¥É¥Ð¥ó¥¹¥È¶µ°é¡¡Î×¾²¼£ÎųØ(Clinical Therapeutics) ÆóµÜ¡¡¾»¼ù Á°´ü 0.5 5
¢£Î×¾²Åý·×³Ø¡Ê¥¢¥É¥Ð¥ó¥¹¥È¶µ°é¡Ë ÈÓ¸¶¡¡¤Ê¤ª¤ß ¸å´ü 0.5 5
¢£¼£¸³¶È̳³Ø¡ÊOccupation of Clinical Trial¡Ë¡Ê¥¢¥É¥Ð¥ó¥¹¥È¶µ°é¡Ë ²ÃÆ£¡¡Á±µ× ¸å´ü 0.5 5
¢£Î×¾²±ÉÍܳءʥ¢¥É¥Ð¥ó¥¹¥È¶µ°é¡Ë °ËÆ£¡¡¹¯°ì ¸å´ü 0.5 5ǯ
¢£Î×¾²±ÉÍܳءʥ¢¥É¥Ð¥ó¥¹¥È¶µ°é¡Ë ÌîÃÏ¡¡ÍµÈþ ¸å´ü 0.5 5ǯ
¢£Î×¾²±ÉÍܳءʥ¢¥É¥Ð¥ó¥¹¥È¶µ°é¡Ë ÆÀ´Ý¡¡Çî»Ë ¸å´ü 0.5 5
¢£Î×¾²±ÉÍܳءʥ¢¥É¥Ð¥ó¥¹¥È¶µ°é¡Ë ÅÏî´¡¡ÀµÃÎ ¸å´ü 0.5 5
¢£ºÇ¿·ÉÂÍý³Ø Áס¡»þ±É Á°´ü 0.5 6
¢£°å³Ø±Ñ¸ì¡Ê¥¢¥É¥Ð¥ó¥¹¥È¶µ°é¡Ë µÜß·¡¡¹¨ Á°´ü 0.5 5~6
¢£¥¢¥É¥Ð¥ó¥¹¥È¶µ°éÎ×¾²Ìô³Ø¥³¡¼¥¹¼Â̳¼Â½¬(Advanced Practice in Clinical Pharmacy) ÆóµÜ¡¡¾»¼ù ÄÌǯ 1.5 5
¢£¥¢¥É¥Ð¥ó¥¹¥È¶µ°é¥×¥í¥°¥é¥àÃÏ°è°åÎÅ¥³¡¼¥¹ ÅÏî´¡¡ÀµÃÎ ¸å´ü 1.5 5
¢£¥¢¥É¥Ð¥ó¥¹¥È¶µ°é¥×¥í¥°¥é¥àÃÏ°è°åÎÅ¥³¡¼¥¹ ÌîÃÏ¡¡ÍµÈþ ¸å´ü 1.5 5
¢£[¥¢¥É¥Ð¥ó¥¹¥È¶µ°é]ÃÏ°è°åÎÅ¥¢¥É¥Ð¥ó¥¹¥È¼Â̳¼Â½¬¥³¡¼¥¹ °ËÆ£¡¡¹¯°ì ¸å´ü 1.5 5
¢£Î×¾²³«È¯¥¢¥É¥Ð¥ó¥¹¥È¼Â½¬¡ÊAdvenced Practice in Clinical Development¡Ë ²ÃÆ£¡¡Á±µ× ¸å´ü 1.5 5
¢£Î×¾²³«È¯¥¢¥É¥Ð¥ó¥¹¥È¼Â½¬¡ÊAdvenced Practice in Clinical Development¡Ë ºç¸¶¡¡µªÏ ¸å´ü 1.5 5
¢£Áí¹çÌô³Ø±é½¬ È÷¹ÍÍ󵭺ܤζµ°÷ ÄÌǯ 2 6